PX Related Analyst Comments
-
Goldman Boost PT on Praxair (PX), Maintains Neutral
-
Jefferies Lowers Price Target and Estimateson Praxair Inc. (PX); Cautious on Volumes, But Bidding Activity Remains High
-
Barclays on U.S. Chemicals: Lowering Earnings on Weak Demand (VAL, PX, PPG, LYB, DD, DOW, CE & APD)
-
Citi Adds Albemarle (ALB) to 'Top Picks Live' List, Removes Praxair (PX)
-
Atlantic Upgrades AGU, CF to Overweight, Downgrades MON, APD to Neutral
-
Barclays Maintains an 'Equalweight' on Praxair Inc. (PX); Consistent Consistency
-
Barclays maintains an 'Overweight' on Air Products & Chemicals (APD); Mean Reversion to Follow Improved Operating Results
-
Jefferies Upgrades, Downgrades, and Tweaks Estimates and Price Targets on Chemical Sector
-
Jefferies Comments on Praxair's (PX) Two new HyCO Projects, Maintains Buy Rating and $122 PT
-
KeyBanc Raises Price Target on Air Products & Chemicals (APD), Strong Growth and Operating Margin Potential
-
Jefferies Maintains a 'Buy' on Praxair (PX); Strong Q1; Multiple Levers to Sustain Growth
-
Jefferies Raises Price Target on Praxair Inc. (PX), Maintains Buy Rating
-
Jefferies Raises Estimates and Price Target on Praxair Inc. (PX), Maintains Buy Rating
-
KeyBanc Raises Estimates and Price Target on Praxair (PX), Maintains Buy Rating
-
Citi Maintains a 'Buy' on Praxair (PX); Stellar Quarter Led by Broad-Based Volume Gains
-
Soleil Cuts Target on Praxair (PX) to $95 Amid Expected Slowdown in Volume Growth
-
Citi 2Q Chemicals Earnings Preview: Weaker Chemical Trade to Portend 2H Slowdown?
-
Soleil Securities Maintains a 'Buy' on Praxair (PX); Raises PT to $100
-
Goldman Sachs Lifts Price Targets On Chemical Stocks (DOW, ALB, DD, EMN, more...)
-
Goldman Sachs added Air Products (APD) to its Conviction Buy List; Praxair (PX) Removed
-
Soleil Securities Maintains 'Buy' on Praxair (PX), Lowers Price Target to $90
-
Soleil Raises Price Target on Praxair (PX) from $102 to $109
-
Soleil Securities Group Raises Price Target on Praxair (PX) to $102
-
KeyBanc Reiterates Their Buy Rating on Air Products and Chemicals (APD) and Raises Their Price Target
-
UBS raises its price target on Praxair Inc. (PX) to $78
-
Jefferies Says CEO-Led Buyout Offer for MacDermid (MRD) Could Start Trend
Back to PX Stock Lookup
